iRhythm

Verily, iRhythm ink deal to create a-fib screening, diagnosis tools
By Laura Lovett | 01:08 pm | September 05, 2019
The pair will be targeting patients with asymptomatic or silent atrial fibrillation. 

MobiHealthNews

© current_year MobiHealthNews is a publication of HIMSS Media